296 related articles for article (PubMed ID: 9168813)
1. Hypoxia-induced apoptosis in human cells with normal p53 status and function, without any alteration in the nuclear protein level.
Amellem O; Stokke T; Sandvik JA; Smedshammer L; Pettersen EO
Exp Cell Res; 1997 May; 232(2):361-70. PubMed ID: 9168813
[TBL] [Abstract][Full Text] [Related]
2. The retinoblastoma gene product is reversibly dephosphorylated and bound in the nucleus in S and G2 phases during hypoxic stress.
Amellem O; Stokke T; Sandvik JA; Pettersen EO
Exp Cell Res; 1996 Aug; 227(1):106-15. PubMed ID: 8806457
[TBL] [Abstract][Full Text] [Related]
3. Selection of human cervical epithelial cells that possess reduced apoptotic potential to low-oxygen conditions.
Kim CY; Tsai MH; Osmanian C; Graeber TG; Lee JE; Giffard RG; DiPaolo JA; Peehl DM; Giaccia AJ
Cancer Res; 1997 Oct; 57(19):4200-4. PubMed ID: 9331075
[TBL] [Abstract][Full Text] [Related]
4. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of hypoxia on etoposide-induced apoptosis according to the cancer cell lines.
Cosse JP; Sermeus A; Vannuvel K; Ninane N; Raes M; Michiels C
Mol Cancer; 2007 Sep; 6():61. PubMed ID: 17894897
[TBL] [Abstract][Full Text] [Related]
6. Normal p53 status and function despite the development of drug resistance in human breast cancer cells.
Wosikowski K; Regis JT; Robey RW; Alvarez M; Buters JT; Gudas JM; Bates SE
Cell Growth Differ; 1995 Nov; 6(11):1395-403. PubMed ID: 8562478
[TBL] [Abstract][Full Text] [Related]
7. Inactivation of p53 increases the cytotoxicity of camptothecin in human colon HCT116 and breast MCF-7 cancer cells.
Gupta M; Fan S; Zhan Q; Kohn KW; O'Connor PM; Pommier Y
Clin Cancer Res; 1997 Sep; 3(9):1653-60. PubMed ID: 9815856
[TBL] [Abstract][Full Text] [Related]
8. Induction of Fas expression and augmentation of Fas/Fas ligand-mediated apoptosis by the synthetic retinoid CD437 in human lung cancer cells.
Sun SY; Yue P; Hong WK; Lotan R
Cancer Res; 2000 Nov; 60(22):6537-43. PubMed ID: 11103825
[TBL] [Abstract][Full Text] [Related]
9. Influence of p53 and caspase 3 activity on cell death and senescence in response to methotrexate in the breast tumor cell.
Hattangadi DK; DeMasters GA; Walker TD; Jones KR; Di X; Newsham IF; Gewirtz DA
Biochem Pharmacol; 2004 Nov; 68(9):1699-708. PubMed ID: 15450935
[TBL] [Abstract][Full Text] [Related]
10. Differential chemosensitivity of breast cancer cells to ganciclovir treatment following adenovirus-mediated herpes simplex virus thymidine kinase gene transfer.
Li PX; Ngo D; Brade AM; Klamut HJ
Cancer Gene Ther; 1999; 6(2):179-90. PubMed ID: 10195885
[TBL] [Abstract][Full Text] [Related]
11. p53-mediated up-regulation of CD95 is not involved in genotoxic drug-induced apoptosis of human breast tumor cells.
Ruiz-Ruiz MC; López-Rivas A
Cell Death Differ; 1999 Mar; 6(3):271-80. PubMed ID: 10200578
[TBL] [Abstract][Full Text] [Related]
12. Photodynamic therapy sensitivity is not altered in human tumor cells after abrogation of p53 function.
Fisher AM; Ferrario A; Rucker N; Zhang S; Gomer CJ
Cancer Res; 1999 Jan; 59(2):331-5. PubMed ID: 9927042
[TBL] [Abstract][Full Text] [Related]
13. Down regulation of p53 with HPV E6 delays and modifies cell death in oxidant response of human diploid fibroblasts: an apoptosis-like cell death associated with mitosis.
Chen QM; Merrett JB; Dilley T; Purdom S
Oncogene; 2002 Aug; 21(34):5313-24. PubMed ID: 12149652
[TBL] [Abstract][Full Text] [Related]
14. Ribozyme targeted on HPV16E6 mRNA induced apoptosis on human cervical carcinoma CaSKi cells.
Zheng YF; Zhang JR
Ai Zheng; 2003 May; 22(5):458-62. PubMed ID: 12753702
[TBL] [Abstract][Full Text] [Related]
15. Differential involvement of the CD95 (Fas/APO-1) receptor/ligand system on apoptosis induced by the wild-type p53 gene transfer in human cancer cells.
Fukazawa T; Fujiwara T; Morimoto Y; Shao J; Nishizaki M; Kadowaki Y; Hizuta A; Owen-Schaub LB; Roth JA; Tanaka N
Oncogene; 1999 Apr; 18(13):2189-99. PubMed ID: 10327065
[TBL] [Abstract][Full Text] [Related]
16. p53 checkpoint-defective cells are sensitive to X rays, but not hypoxia.
Denko NC; Green SL; Edwards D; Giaccia AJ
Exp Cell Res; 2000 Jul; 258(1):82-91. PubMed ID: 10912790
[TBL] [Abstract][Full Text] [Related]
17. Effects of hypoxia on radiation-responsive stress-activated protein kinase, p53, and caspase 3 signals in TK6 human lymphoblastoid cells.
Samuni AM; Kasid U; Chuang EY; Suy S; Degraff W; Krishna MC; Russo A; Mitchell JB
Cancer Res; 2005 Jan; 65(2):579-86. PubMed ID: 15695402
[TBL] [Abstract][Full Text] [Related]
18. RNA interference-mediated silencing of the p53 tumor-suppressor protein drastically increases apoptosis after inhibition of endogenous fatty acid metabolism in breast cancer cells.
Menendez JA; Lupu R
Int J Mol Med; 2005 Jan; 15(1):33-40. PubMed ID: 15583825
[TBL] [Abstract][Full Text] [Related]
19. Role of p53 in G2/M cell cycle arrest and apoptosis in response to gamma-irradiation in ovarian carcinoma cell lines.
Concin N; Stimpfl M; Zeillinger C; Wolff U; Hefler L; Sedlak J; Leodolter S; Zeillinger R
Int J Oncol; 2003 Jan; 22(1):51-7. PubMed ID: 12469184
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxic effects of adenovirus-mediated wild-type p53 protein expression in normal and tumor mammary epithelial cells.
Katayose D; Gudas J; Nguyen H; Srivastava S; Cowan KH; Seth P
Clin Cancer Res; 1995 Aug; 1(8):889-97. PubMed ID: 9816059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
